![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | June 2023
The Government has recognised “unlocking institutional investment”, particularly DC pension capital, as a long-term ambition and has announced “an ambitious life sciences package to support economic growth”.
It has now published a summary of responses to its March 2023 call for feedback on the Long-term Investment for Technology and Science (LIFTS) initiative, on which it is working with the British Business Bank (BBB). The objectives of the BBB are to unlock UK institutional investment, encourage investment into UK science and technology companies and to stimulate venture capital. In its development of the LIFTS project, the BBB has called for proposals from industry, with announcements of those to be taken forward expected in November 2023. The submission deadline for proposals is July 28, 2023.
The PLSA has also published a paper identifying measures to increase pension fund investment in UK growth.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023